ArticlePharmaceutics2019

Population Pharmacokinetics Modelling and Simulation of Mitotane in Patients with Adrenocortical Carcinoma: An Individualized Dose Regimen to Target All Patients at Three Months?

Yoann Cazaubon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.